重症患者脓毒症相关急性肾损伤的流行病学:韩国多中心前瞻性观察性队列研究
该研究为韩国多中心、前瞻性、观察性队列的二次分析,纳入2019年9月至2022年12月因脓毒症入住ICU的≥19岁患者5100例,采用急性疾病质量倡议(ADQI)28工作组新共识定义SA-AKI。结果显示3177例(62.3%)发生SA-AKI,其中1期613例(19.3%)、2期721例(22.7%)、3期1843例(58.0%)。重症SA-AKI(2期与3期合并)与院内死亡风险升高相关;遵循1小时脓毒症集束化治疗中的液体复苏部分与重症SA-AKI患者院内死亡风险降低相关(校正OR 0.62,95%CI 0.48-0.79,P<0.001)。
要点
- ICU脓毒症患者SA-AKI发生率为62.3%(3177/5100),其中3期占58.0%(1843例),2期占22.7%(721例),1期占19.3%(613例)。
- 重症SA-AKI(2期与3期合并)与院内死亡风险升高相关。
- 遵循1小时脓毒症集束化治疗中的液体复苏部分与重症SA-AKI患者院内死亡风险降低相关(校正OR 0.62,95%CI 0.48-0.79,P<0.001)。
- SA-AKI定义采用急性疾病质量倡议(ADQI)28工作组新共识定义。
适用人群与场景
- 年龄≥19岁、因脓毒症诊断入住重症监护室的患者(韩国多中心前瞻性队列)。
诊断标准与关键阈值
- SA-AKI诊断采用急性疾病质量倡议(ADQI)28工作组新共识定义,分期为1期、2期、3期,重症SA-AKI为2期与3期合并。
处置流程与药物剂量
- 遵循1小时脓毒症集束化治疗中的液体复苏部分与重症SA-AKI患者院内死亡风险降低相关(校正OR 0.62,95%CI 0.48-0.79,P<0.001)。
研究设计与关键结果
- 研究类型:多中心、前瞻性、观察性队列研究的二次分析;样本量5100例;人群为因脓毒症入住ICU的≥19岁患者;主要终点SA-AKI发生率62.3%(3177例),其中1期613例(19.3%)、2期721例(22.7%)、3期1843例(58.0%)。
- 重症SA-AKI(2期与3期合并)与院内死亡风险升高相关。
- 遵循1小时脓毒症集束化治疗中的液体复苏部分与重症SA-AKI患者院内死亡风险降低相关(校正OR 0.62,95%CI 0.48-0.79,P<0.001)。
证据类型、等级与局限
- 证据类型:多中心、前瞻性、观察性队列研究的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,遵循1小时脓毒症集束化治疗中的液体复苏部分可能改善重症SA-AKI患者的结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Despite the clinical importance of sepsis-associated acute kidney injury (SA-AKI), little is known about its epidemiology. We aimed to investigate the incidence and outcomes of SA-AKI, as well as the risk factors for mortality among patients with severe SA-AKI in critically ill patients.
METHODS: This secondary multicenter, observational, prospective cohort analysis of sepsis in South Korea evaluated patients aged ≥ 19 years admitted to intensive care units with a diagnosis of sepsis. The primary outcome was the incidence of SA-AKI, defined using the new consensus definition of the Acute Disease Quality Initiative 28 Workgroup. Secondary outcomes were in-hospital mortality and risk factors for in-hospital mortality.
RESULTS: Between September 2019 and December 2022, 5100 patients were admitted to intensive care units with a diagnosis of sepsis, and 3177 (62.3%) developed SA-AKI. A total of 613 (19.3%), 721 (22.7%), and 1843 (58.0%) patients had stage 1, 2, and 3 SA-AKI, respectively. Severe SA-AKI (stages 2 and 3 combined) was associated with an increased risk of in-hospital mortality. Adherence to the fluid resuscitation component of the one-hour sepsis bundle was associated with a decreased risk of in-hospital mortality in severe SA-AKI (adjusted odds ratio, 0.62; 95% confidence interval, 0.48-0.79; P < 0.001).
CONCLUSIONS: Of the patients admitted to the intensive care unit for sepsis, 62.3% developed SA-AKI. Severe SA-AKI was associated with an increased risk of mortality. Adherence to the fluid resuscitation component of the one-hour sepsis bundle can potentially improve outcomes in these patients.
参考来源
- Song MJ, Jang Y, Legrand M, et al. Epidemiology of sepsis-associated acute kidney injury in critically ill patients: a multicenter, prospective, observational cohort study in South Korea. Crit Care. 2024. PMID: 39581988. doi:10.1186/s13054-024-05167-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。